| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |